Preview

Пульмонология

Расширенный поиск

Аллергический ринит и сопутствующая бронхиальная астма. Механизмы взаимосвязи и подходы к фармакотерапии

https://doi.org/10.18093/0869-0189-2006-3-100-106

Полный текст:

Аннотация

Аллергический ринит часто сопутствует бронхиальной астме (БА) и оказывает значительное негативное влияние на ее течение, что свидетельствует об общности патогенетических механизмов возникновения и развития заболеваний, а также о возможной взаимосвязи
клинических проявлений и патофизиологии аллергического воспаления слизистой верхних и нижних дыхательных путей. При сопутствующем аллергическом рините контроль астмы не возможен без адекватной терапии патологии верхних дыхательных путей. Наибольшим клиническим и противовоспалительным эффектом при аллергическом рините обладают интраназальные кортикостероиды, которые также имеют выраженные протективные свойства в отношении сопутствующей БА.

Об авторах

Л.М. Огородова

Россия


Ф.И. Петровский

Россия


Список литературы

1. Огородова Л.М., Петровский Ф.И., Коростовцев Д.С. и др. Тяжелая бронхиальная астма у детей: результаты многоцентрового национального исследования НАБАТ. Аллергология 2004; 2: 3-9.

2. Чучалин А.Г., Огородова Л.М., Петровский Ф.И. и др. Мониторирование и лечение тяжелой бронхиальной астмы у взрослых: результаты национального многоцентрового исследования НАБАТ. Тер.арх. 2005; 3: 12-20.

3. Adams R.J., Fuhlbrigge A.L., Finkelstein J.A. et al. Intranasal steroids and the risk of emergency department visits for asthma. J. Allergy Clin. Immunol. 2002; 109: 636-642.

4. Bensch G.W., Nelson H.S., Borish L.C. Evaluation of cytokines in nasal secretions after nasal antigen challenge: lack of influence of antihistamines. Ann. Allergy Asthma Immunol. 2002; 88: 457-462.

5. Borish L. Allergic rhinitis: Systemic inflammation and implications for management. J. Allergy Clin. Immunol. 2003; 112: 1021-1031.

6. Bousquet J., van Cauwenberge P., Khaltaev N. Allergic rhinitis and its impact on Asthma: ARIA workshop report. J. Allergy Clin. Immunol. 2001; 108: S147-S334.

7. Bousquet J., Neukirch F., Bousquet P.J., et al. Severity and impairment of allergic rhinitis in patients consulting in primary care. J. Allergy Clin. Immunol. 2006; 117: 158-162.

8. Braunstahl G.J., Kleinjan A., Overbeek S.E. et al. Segmental bronchial provocation induces nasal inflammation in allergic rhinitis patients. Am. J. Respir. Crit. Care Med. 2000; 161: 2051-2057.

9. Braunstahl G.J., Overbeek S.E., Kleinjan A. et al. Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways. J. Allergy Clin. Immunol. 2001; 107: 469-476.

10. Corren J., Adinoff A.D., Buchmeier A.D. et al. Nasal beclomethasone prevents the seasonal increase in bronchial responsiveness in patients with allergic rhinitis and asthma. J. Allergy Clin. Immunol. 1992; 90: 250.

11. Corren J., Adinoff A.D., Irvin C.G. Changes in bronchial responsiveness following nasal provocation with allergen. J. Allergy Clin. Immunol. 1992; 89: 611-618.

12. Corren J., Harris A., Aaronson D. et al. Efficacy and safety of loratadine plus pseudoephedrine in patients with seasonal allergic rhinitis and mild asthma. J. Allergy Clin. Immunol. 1997; 100: 781-788.

13. Corren J. The link between allergic rhinitis and asthma, otitis media, sinusitis, and nasal polyps. Immunol. Allergy Clin. N. Am. 2000; 20: XXX.

14. Crystal-Peters J. Treating allergic rhinitis in patients with comorbid asthma: the risk of asthma-related hospitalizations and emergency department visits. J. Allergy Clin. Immunol. 2002; 109: 57-62.

15. Cuffel B., Wamboldt M., Borish L.C. et al. Economic consequences of comorbid depression, anxiety, and allergic rhinitis. Psychosomatics 1999; 40: 491-496.

16. D'Alonzo G.E. Scope and impact of allergic rhinitis. J. Am. Osteopath. Assoc. 2002; 102: S2-S6.

17. Des-Roches A., Paradis L., Ménardo J.-L. et al. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children. J. Allergy Clin. Immunol. 1997; 99: 450-453.

18. Dykewicz M.S., Fineman S., Skoner D.P. et al. Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. Ann. Allergy Asthma Immunol. 1998; 81: 478-518.

19. Failla M., Biondi G., Provvidenza Pistorio M. et al. Intranasal steroid reduces exhaled bronchial cysteinyl leukotrienes in allergic patients. Clin. Exp. Allergy 2006; 36 (3): 325-330.

20. Fineman S.M. The burden of allergic rhinitis: beyond dollars and cents. Ann. Allergy Asthma Immunol. 2002; 88: 2-7.

21. Fireman P. Treatment of allergic rhinitis: effect on occupation productivity and work force costs. Allergy Asthma Proc. 1997; 18: 63-67.

22. Fontanari P., Burnet H., Zattara-Harmann M.C. et al. Changes in airway resistance induced by nasal inhibitor of cold dry, dry, or moist air in normal individuals. J. Appl. Physiol. 1996; 81: 1739.

23. Foresi A., Pelucchi A., Gherson G. et al. Once daily intranasal fluticasone propionate (200 μg) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis. J. Allergy Clin. Immunol. 1996; 98: 274-282.

24. Global Initiative for Asthma Workshop Report 2004 [Электронный ресурс]. - Электрон. дан. - Режим доступа : http://www.ginasthma.com/

25. Bateman E.D., Boushey H.A. , Bousquet J. et al. GOAL Investigators Group. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am. J. Respir. Crit. Care Med. 2004; 170 (8): 836-844.

26. Grant J.A., Nicodemus C.F., Findlay S.R. et al. Cetirizine in patients with seasonal allergic rhinitis and concomitant asthma: Prospective, randomized, placebo-controlled trial. J. Allergy Clin. Immunol. 1995; 95: 923.

27. Griffin M.P., McFadden E.R., Ingram R.H. Airway cooling in asthmatic and nonasthmatic subjects during nasal and oral breathing. J. Allergy Clin. Immunol. 1982; 69: 354.

28. Halpern M., Richner R., Togias A. et al. Allergic rhinitis may increase asthma costs. Am. J. Respir. Crit. Care Med. 1996; 153: A860.

29. Hamilos D.L., Leung D.Y., Wood R. et al. Evidence for distinct cytokine expression in allergic versus nonallergic chronic sinusitis. J. Allergy Clin. Immunol. 1995; 96: 537-544.

30. Henriksen J.W., Wenzel A. Effect of an intranasally administered corticosteroid (budesonide) on nasal obstruction, mouth breathing and asthma. Am. Rev. Respir. Dis. 1984; 130: 1014.

31. Johnstone D.E. Immunotherapy in children: past, present, and future: Part I. Ann. Allergy 1981; 46: 1-7.

32. Kapsali T., Horowitz E., Diemer F. et al. Rhinitis is ubiquitous in allergic asthmatics. J. Allergy Clin. Immunol. 1997; 99: S138.

33. Kaszuba S.M., Baroody F.M., deTineo M. et al. Superiority of an intranasal corticosteroid compared with an oral antihistamine in the as-needed treatment of seasonal allergic rhinitis. Arch. Intern. Med. 2001; 161: 2581-2587.

34. Kaufman J., Chen J., Wright G.W. The effect of trigeminal resection on reflex bronchoconstriction after nasal and nasopharyngeal irritation in man. Am. Rev. Respir. Dis. 1970; 101: 768.

35. Kaufman J., Wright G.W. The effect of nasal and nasopharyngeal irritation on airway resistance in man. Am. Rev. Respir. Dis.1969; 100: 626.

36. Kivisaari E., Baker R.C., Price M.J. Comparison of once daily fluticasone propionate aqueous nasal spray with once daily budesonide reservoir powder device in patients with perennial rhinitis. Clin. Exp. Allergy 2001; 31 (6). - P. 855-863.

37. Kremer B., Den Hartog H.M., Jolles J. Relationship between allergic rhinitis, disturbed cognitive functions and psychological well-being. Clin. Exp. Allergy 2002; 32: 1310-1315.

38. Lai L., Casale T.B., Stokes J. Pediatric Allergic Rhinitis: Treatment. Immunol. Allergy Clin. N. Am. 2005; 25: 283-299.

39. Marshall P.S., O'Hara C., Steinberg P. Effects of seasonal allergic rhinitis on selected cognitive abilities. Ann. Allergy Asthma Immunol. 2000; 84: 403-410.

40. Moller C., Dreborg S., Ferdousi H.A., et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J. Allergy Clin. Immunol. 2002; 109 (2): 251-256.

41. Prenner B.M., Schenkel E. Allergic rhinitis: treatment based on patient profiles. Am. J. Med. 2006; 119: 230-237.

42. Salib R.J., Drake-Lee A., Howarth P.H. Allergic rhinitis: past, present and the future. Clin. Otolaryngol. Allied Sci. 2003; 28: 291-303.

43. Shturman-Ellstein R., Zeballos R.J., Buckley J.M. et al. The beneficial effect of nasal breathing on exercise-induced bronchoconstriction. Am. Rev. Respir. Dis. 1978; 118: 65.

44. Sly R.M. Changing prevalence of allergic rhinitis and asthma. Ann. Allergy Asthma Immunol. 1999; 82: 233.

45. Smart B.A., Slavin R.G. Rhinosinusitis and pediatric asthma. Immunol. Allergy Clin. N. Am. 2005; 25: 67-82.

46. Stelmach R., Nunes M.P.T., Ribeiro M. et al. Effect of treating allergic rhinitis with corticosteroids in patients with mild-to-moderate persistent asthma. Chest 2005; 128: 3140-3147..

47. Tai C.J., Wang P.C. Comparisons of two intranasal corticosteroid preparations in treating allergic rhinitis. Otolaryngol. Head Neck Surg. 2003; 129 (5): 518-525..

48. Togias A., Bieneman A., Bloom D. et al. Changes in blood leukocyte cytokine expression following repeated nasal allergen provocation: evidence for systemic manifestations. J. Allergy Clin. Immunol. 2002; 109 (suppl.): S2362.

49. Tosca M.A., Cosentino C., Pallestrini E. et al. Improvement of clinical and immunopathologic parameters in asthmatic children treated for concomitant chronic rhinosinusitis. Ann. Allergy Asthma Immunol. 2003; 91 (1): 71-78.

50. US Food and Drug Administration. Center for Drug Evaluation and Research. Nasonex / Mometasone Furoate Medical Review, Part 2. 1997 [Электронный ресурс]. - Электрон. дан. - Режим доступа: http://www.fda.gov/cder/foi/nda/97/020762ap_Nasonex_medrP2.pdf

51. Watson W.T.A., Becker A.B., Simons F.E.R. Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: Effect on lower airway responsiveness. J. Allergy Clin. Immunol. 1993; 91: 97.

52. Welsh P.W., Stricker E.W., Chu-Pin C. et al. Efficacy of beclomethasone nasal solution, flunisolide and cromolyn in relieving symptoms of ragweed allergy. Mayo Clin. Proc. 1987; 62: 125.


Для цитирования:


Огородова Л., Петровский Ф. Аллергический ринит и сопутствующая бронхиальная астма. Механизмы взаимосвязи и подходы к фармакотерапии . Пульмонология. 2006;(3):100-106. https://doi.org/10.18093/0869-0189-2006-3-100-106

Просмотров: 3


ISSN 0869-0189 (Print)
ISSN 2541-9617 (Online)